Detomidine hydrochloride
CAS : 90038-01-0
Ref. 3D-FD21398
| 1g | Arrêté | ||
| 2g | Arrêté | ||
| 5g | Arrêté | ||
| 250mg | Arrêté | ||
| 500mg | Arrêté |
Informations sur le produit
Nom :
Detomidine hydrochloride
Synonymes :
- 5-[(2,3-Dimethylphenyl)methyl]-1H-imidazole hydrochloride4-[(2,3-Dimethylphenyl)methyl]-1H-imidazole monohydrochlorideDomosedan
- 1H-Imidazole, 4-[(2,3-dimethylphenyl)methyl]-, monohydrochloride
- 1H-Imidazole, 5-[(2,3-dimethylphenyl)methyl]-, hydrochloride (1:1)
- 4-[(2,3-Dimethylphenyl)methyl]-1H-imidazole monohydrochloride
- 5-(2,3-dimethylbenzyl)-1H-imidazole hydrochloride (1:1)
- Domosedan
- Dormosedan
- Mpv 253Aii
Description :
Detomidine hydrochloride is a sedative that is used to manage pain in animals. It has a clinical relevance in the treatment of convulsions, seizures, and tetanus. Detomidine hydrochloride has been shown to have 2-adrenergic receptor agonist activity and can cause the release of energy substrates from cells. The drug also alters cardiac function by causing an increase in blood pressure, heart rate, and cardiac output. Detomidine hydrochloride has been shown to alter microdialysis probes for physiological effects such as estradiol benzoate concentration and cortisol concentrations. This drug also has locomotor activity effects on rats that can be inhibited with nonsteroidal anti-inflammatory drugs such as ibuprofen.
Avis:
Nos produits sont destinés uniquement à un usage en laboratoire. Pour tout autre usage, veuillez nous contacter.
Marque:
Biosynth
Stockage à long terme :
Notes :
Propriétés chimiques
Masse moléculaire :
222.71 g/mol
Formule :
C12H15ClN2
Degré de pureté :
Min. 95%
MDL:
Point de fusion :
Point d'ébullition :
Point d'éclair :
Densité :
Concentration :
EINECS :
Merck :
Code SH :
